Mid Trent Cancer Network - Information for you (i4u)

Cancer Research UK's Drug Development Office has launched a clinical trial to test an experimental drug in patients with advanced (Stage IV) pancreatic cancer - one of the most difficult cancers to treat.

A NEW survey released today (Wednesday 1 September) reveals almost half of Brits (46 per cent) got sunburnt this year. Of those who got burnt, a third (32 per cent) admitted their motivation was to get a tan. And half of those who burnt whilst trying to get a tan would risk burning again next year.

Oesophageal cancer rates in men have risen by 50 per cent over the last 25 years, according to new figures published by Cancer Research UK today.

An experimental drug designed to treat cancers with a particular genetic fault has shown promising results in a small clinical trial.

The National Institute for Health and Clinical Excellence (NICE) has released draft guidance which recommends the drugs bortezomib and thalidomide as first-line therapies for some patients with multiple myeloma, a type of cancer that affects cells in the bone marrow.

A new study suggests that tobacco companies may be using online video portals, such as YouTube, to get around advertising restrictions and market their products to young people.

CANCER RESEARCH TECHNOLOGY has signed an agreement with Bayer Schering Pharma AG, Germany to evaluate new leptin antagonist peptides as potential experimental treatments initially in the area of gynaecological diseases, including cancer.

The National Institute for Health and Clinical Excellence (NICE) has released draft guidance for cancer drug bevacizumab (Avastin).

UK scientists at the University of Oxford have discovered that vitamin D can affect the activity of more than 200 genes of cells grown in the lab. Some of these genes are known from previous studies to be involved in diseases like diabetes and cancer.

A US study, published in the Journal of the National Cancer Institute, has confirmed suggestions that certain types of breast cancer are more common among women who regularly drink alcohol.

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

NHS Stop Smoking Services helped 373,954 people to quit smoking during 2009-10 - a higher number than ever before.

The number of 16 and 17 year old smokers has dropped since it became illegal to sell cigarettes to under 18s according to new research published in Addiction today (Wednesday).

Two Cancer Research UK scientists were recently awarded prestigious Royal Society Awards, while a number of Cancer Research UK scientists were elected fellows of the Royal Society and the Academy of Medical Sciences.

An experimental drug called olaparib has been shown to shrink tumours in women whose advanced cancers were caused by faults in their BRCA genes.

A US study has found that a daily dose of aspirin may reduce the risk of prostate cancer, but Cancer Research UK has noted that regular use of aspirin can cause serious side-effects and should not be undertaken unless recommended by a doctor.

A LINK between the level of active DNA repair genes in melanoma tumours and the effectiveness of chemotherapy for skin cancer patients has been established for the first time by a team of scientists.

CANCER RESEARCH TECHNOLOGY has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.

Breast cancer death rates have fallen steeply in the UK in the last 20 years - and at a faster rate than in any other European country except for Iceland, a new study has found.

A test using a patient's breath could be developed to detect lung, breast, bowel and prostate cancers, a team of scientists have discovered.